Fugene 6 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (5)
Papers in which this entity is mentioned.
- Genetic compensation triggered by mutant mRNA degradation. (2019)
- EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. (2018)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- A role for human homologous recombination factors in suppressing microhomology-mediated end joining. (2016)
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| fugene 6 | drug | 12 | 16 |